Designing a life-prolonging regimen for patients with type 1 diabetes
Paris: A new study has found that an implant of stem cells in the liver of type 1 diabetes patients can extend their lives. A trial led by French scientists showed encouraging results for patients with type 1 diabetes (who underwent kidney transplants). About one-third of people with type 1 diabetes will eventually need a…